Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report-Reference-Cited by-同舟云学术

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report

Published:1995 Issue:1 Volume:24 Page:109-122
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neuro-Oncol

Author:

Bigner Darell D.,Brown Mark,Coleman R. Edward,Friedman Allan H.,Friedman Henry S.,McLendon Roger E.,Bigner Sandra H.,Zhao Xiao -Guang,Wikstrand Carol J.,Pegram Charles N.,Kerby Tracy,Zalutsky Michael R.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01052668.pdf

Reference48 articles.

1. Ehrlich P: Ueber ein transplantables Chondrom der maus. Arbeiten aus dem Königlichen Institut für Experimentelle Therapie zu Frankfurt A.M. 1: 5?73, 1906

2. Ehrlich P: Referat ber die genese des carcinomas. Verhandlungen der Deutschen Pathologischen Gesellschaft 12: 13?32, 1908

3. Ehrlich P: Über den jetzigen Stand der Karzinomforschung. In: Himmelweit F (ed) The Collected Papers of Paul Ehrlich, Vol. II. Pergamon Press, London, 1957, pp 550?562

4. Landsteiner K: Cell antigens and individual specificity. J Immunol 15: 589?600, 1928

5. Pressman D, Day ED, Blau M: The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res 17: 845?850, 1957

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical advances in TNC delivery vectors and their conjugate agents;Pharmacology & Therapeutics;2024-01

2. Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors;Future Oncology;2023-08

3. Radiolabeled Antibodies for Cancer Imaging and Therapy;Cancers;2022-03-11

4. Radionuclide Leptomeningeal Metastasis Therapy Trials;Radiopharmaceuticals in the Management of Leptomeningeal Metastasis;2022

5. State of Art of LM Therapies: Intrathecal and Systemic Approaches;Radiopharmaceuticals in the Management of Leptomeningeal Metastasis;2022